Evaluation of the relationship body mass index (BMI) to response and tolerability after treatment with sumatriptan 85 mg formulated with RT technology/naproxen sodium 500 mg (SumaRT/Nap) for the early intervention treatment of migraine
CEPHALALGIA（2009）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要